JP2016508487A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508487A5
JP2016508487A5 JP2015555384A JP2015555384A JP2016508487A5 JP 2016508487 A5 JP2016508487 A5 JP 2016508487A5 JP 2015555384 A JP2015555384 A JP 2015555384A JP 2015555384 A JP2015555384 A JP 2015555384A JP 2016508487 A5 JP2016508487 A5 JP 2016508487A5
Authority
JP
Japan
Prior art keywords
phenyl
naphthyridin
hydrazinecarbonyl
ethynyl
biphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/013204 external-priority patent/WO2014117090A1/en
Publication of JP2016508487A publication Critical patent/JP2016508487A/ja
Publication of JP2016508487A5 publication Critical patent/JP2016508487A5/ja
Pending legal-status Critical Current

Links

JP2015555384A 2013-01-28 2014-01-27 金属酵素阻害剤化合物 Pending JP2016508487A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361757594P 2013-01-28 2013-01-28
US61/757,594 2013-01-28
PCT/US2014/013204 WO2014117090A1 (en) 2013-01-28 2014-01-27 Metalloenzyme inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2016508487A JP2016508487A (ja) 2016-03-22
JP2016508487A5 true JP2016508487A5 (show.php) 2017-03-02

Family

ID=51228112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555384A Pending JP2016508487A (ja) 2013-01-28 2014-01-27 金属酵素阻害剤化合物

Country Status (6)

Country Link
US (1) US9663488B2 (show.php)
EP (1) EP2948450A4 (show.php)
JP (1) JP2016508487A (show.php)
AU (1) AU2014209107B2 (show.php)
CA (1) CA2898615A1 (show.php)
WO (1) WO2014117090A1 (show.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN06792A (show.php) 2012-01-20 2015-05-22 Viamet Pharmaceuticals Inc
JP2017509646A (ja) 2014-03-19 2017-04-06 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
MX2016012060A (es) 2014-03-19 2017-01-19 Viamet Pharmaceuticals Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
WO2015143162A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
WO2015143154A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
US10017494B2 (en) 2014-03-19 2018-07-10 Mycovia Pharmaceuticals, Inc. Antifungal compound process
WO2015143166A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
BR112016021257B1 (pt) 2014-03-19 2021-03-02 Viamet Pharmaceuticals (NC), Inc. 2-(2,4- difluorofenil-1,1-diflúor-1-(5-substituído-piridin-2-il)-3- (1h-tetrazol-1-il)propan-2-óis e processos para preparação e uso dos mesmos
EP3119745B1 (en) 2014-03-19 2020-08-05 Mycovia Pharmaceuticals, Inc. Antifungal compound process
EP3119754A4 (en) 2014-03-19 2017-12-13 Viamet Pharmaceuticals, Inc. Antifungal compound process
CN107074773A (zh) 2014-09-09 2017-08-18 拜耳制药股份公司 取代的n,2‑二芳基喹啉‑4‑甲酰胺及其用途
WO2016061280A1 (en) 2014-10-14 2016-04-21 La Jolla Institute Of Allergy & Immunology Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
CA2979926A1 (en) * 2015-03-18 2016-09-22 Bayer Pharma Aktiengesellschaft Substituted n-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof
WO2017049096A1 (en) 2015-09-18 2017-03-23 Viamet Pharmaceuticals, Inc. Antifungal compound process
CN105272896A (zh) * 2015-10-19 2016-01-27 山东国润生物医药有限公司 ((2s)-2-氮丙啶基)二苯基甲醇的制备方法
ES2909122T3 (es) 2015-11-09 2022-05-05 Forge Therapeutics Inc Compuestos a base de hidroxipiridinona e hidroxipirimidinona para el tratamiento de infecciones bacterianas
WO2017083434A1 (en) 2015-11-09 2017-05-18 Forge Therapeutics, Inc. Pyrone based compounds for treating bacterial infections
WO2017153234A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylchinolin-4-carboxamide und ihre verwendung
WO2017153235A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung
WO2017153231A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylisochinolinon-4-carboxamide und ihre verwendung
JP2019142776A (ja) * 2016-06-24 2019-08-29 石原産業株式会社 N−(4−ピリジル)ベンズアミド化合物又はその塩を有効成分として含有する有害生物防除剤
MX378460B (es) 2016-12-22 2025-03-10 Calithera Biosciences Inc Composiciones y métodos para inhibir la actividad de la arginasa.
CN110730776A (zh) 2017-04-10 2020-01-24 拜耳股份公司 取代的n-芳基乙基-2-芳基喹啉-4-甲酰胺及其用途
TWI770157B (zh) 2017-04-10 2022-07-11 德商拜耳廠股份有限公司 經取代之n-芳基乙基-2-胺基喹啉-4-甲醯胺及其用途
WO2018204176A1 (en) * 2017-05-01 2018-11-08 Sanford Burnham Prebys Medical Discovery Institute Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof
EP3621962A4 (en) 2017-05-10 2020-12-09 Forge Therapeutics, Inc. ANTIBACTERIAL COMPOUNDS
EP3793562B1 (en) * 2018-06-22 2024-06-19 Ohio State Innovation Foundation Methods and compositions for inhibition of dihydroorotate dehydrogenase
KR20210070308A (ko) 2018-09-20 2021-06-14 포지 테라퓨틱스, 인크. 항균 화합물
CN109456205B (zh) * 2018-12-17 2021-09-21 石河子大学 以取代喹啉或异喹啉酰肼吡啶-n-氧化物为配体的水相体系中的n-芳基化方法
EP3725788A1 (en) * 2019-04-15 2020-10-21 Bayer AG Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides
WO2021195260A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
WO2023055686A1 (en) 2021-09-28 2023-04-06 Blacksmith Medicines, Inc. Lpxc inhibitors and uses thereof
WO2023219456A1 (ko) * 2022-05-12 2023-11-16 숙명여자대학교 산학협력단 퀴놀린 계열 히스톤디아세틸화 효소 저해활성물질, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
EP4534083A4 (en) * 2022-05-30 2025-11-19 Scinnohub Pharmaceutical Co Ltd USE OF A TETRAHYDRONAPHTYRIDINE DERIVATIVE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF DISEASES RELATED TO ADHESION

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA845594B (en) * 1983-07-22 1986-03-26 Du Pont Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
JPH083163A (ja) * 1994-06-22 1996-01-09 Kyowa Hakko Kogyo Co Ltd 縮合ピリジン誘導体
AU4007900A (en) * 1999-03-11 2000-10-16 Neurogen Corporation Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
AU7622000A (en) * 1999-10-01 2001-05-10 Institute Of Molecular And Cell Biology Compounds for the treatment of viral-mediated diseases
WO2002000623A2 (en) * 2000-06-26 2002-01-03 Neurogen Corporation Aryl fused substituted 4-oxy-pyridines
DE60114227T2 (de) * 2000-08-16 2006-04-20 Neurogen Corp., Branford 2,4-substituierte pyridinderivate
US20040110802A1 (en) * 2002-08-23 2004-06-10 Atli Thorarensen Antibacterial benzoic acid derivatives
WO2005042498A2 (en) * 2003-10-31 2005-05-12 Neurogen Corporation 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
MXPA06006532A (es) * 2003-12-09 2006-08-23 Vertex Pharma Derivados de naftiridina y su uso como moduladores de receptores muscarinicos.
WO2006034491A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
WO2007100775A2 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2008105515A1 (ja) 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
CN101084895B (zh) * 2007-06-22 2011-11-23 复旦大学 一种葡萄球菌色氨酰-tRNA合成酶抑制剂
EP2543368A1 (en) 2007-12-11 2013-01-09 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
JP5455913B2 (ja) * 2008-08-27 2014-03-26 大正製薬株式会社 ナフチリジン−n−オキシドを有する新規ヒドロキサム酸誘導体
WO2010094009A2 (en) * 2009-02-13 2010-08-19 Children's Hospital Medical Center Methods and compositions for the treatment of ras associated disorders
EP2519508B1 (en) 2009-12-31 2014-07-02 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
RU2450025C2 (ru) * 2010-07-16 2012-05-10 Учреждение Российской академии наук Институт высокомолекулярных соединений РАН МЕТАЛЛ-ПОЛИМЕРНЫЙ КОМПЛЕКС ЕВРОПИЯ (Eu3+) И (СО)ПОЛИ-(МЕТИЛМЕТАКРИЛАТ)-(1-МЕТАКРИЛОИЛ-2-(2-ПИРИДИЛ)-4-КАРБОКСИХИНОЛИЛ)ГИДРАЗИНА
BR112013014484A2 (pt) 2010-12-13 2016-07-19 Viamet Pharmaceuticals Inc compostos inibidores de metaloenzimas
CA2830866A1 (en) * 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
CN103781775B (zh) * 2011-06-19 2016-11-16 威尔金制药有限公司 金属酶抑制剂化合物
EP2847168A1 (en) * 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents

Similar Documents

Publication Publication Date Title
JP2016508487A5 (show.php)
JP2014517068A5 (show.php)
US11247981B2 (en) Metalloenzyme inhibitor compounds
US9663488B2 (en) Metalloenzyme inhibitor compounds
JP6085613B2 (ja) 金属酵素阻害薬化合物
JP5828343B2 (ja) 金属酵素阻害化合物
US11040034B2 (en) Metalloenzyme inhibitor compounds
JP2016526535A5 (show.php)
NZ609955A (en) Sgc stimulators
TW200408390A (en) Hetero biaryl derivatives as matrix metalloproteinase inhibitors
JP2016514711A5 (show.php)
JP2014525442A5 (show.php)
JP6071897B2 (ja) 金属酵素阻害化合物
JP2011524362A5 (show.php)
WO2003051906A2 (en) Compounds and methods
JP2019531317A5 (show.php)